Horizon Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29K Sell
1,018
-331
-25% -$8.8K 0.01% 197
2026
Q2
$32.5K Buy
1,349
+656
+95% +$17.2K 0.01% 194
2026
Q1
$19.5K Sell
693
-321
-32% -$8.55K 0.01% 184
2025
Q4
$25.2K Buy
1,014
+645
+175% +$16.3K 0.01% 124
2025
Q3
$9.4K Buy
369
+251
+213% +$6.2K ﹤0.01% 185
2025
Q2
$2.86K Buy
118
+64
+119% +$1.49K ﹤0.01% 198
2025
Q1
$1.37K Buy
+54
New +$1.41K ﹤0.01% 195

Other funds holding PFE

Horizon Financial Services's PFE Position: Q3 2026 in Review

Horizon Financial Services reduced its Pfizer (PFE) stake by 25% in Q3 2026, selling an estimated $8.8K and leaving 1,018 shares worth $29K. The position accounts for 0.01% of the portfolio, ranked #197.

Horizon Financial Services first reported a position in PFE in Q1 2025 and has held it in 7 quarters since. The position peaked at $32.5K in Q2 2026. 2,310 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Horizon Financial Services held 1,018 shares of Pfizer worth $29K as of Q3 2026.
  • Horizon Financial Services sold 331 Pfizer shares in Q3 2026, an estimated $8.8K.
  • Pfizer made up 0.01% of Horizon Financial Services's portfolio in Q3 2026, its #197 holding.
  • Horizon Financial Services first reported a position in Pfizer in Q1 2025 and has held it in 7 quarters since.
  • Horizon Financial Services's Pfizer position peaked at $32.5K in Q2 2026.
  • 2,310 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Horizon Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.